HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian A Lanman Selected Research

Brian A Lanman Research Topics

Disease

8Neoplasms (Cancer)
01/2020 - 09/2012
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2016
2Multiple Myeloma
04/2016 - 01/2016
2Carcinogenesis
02/2015 - 02/2015
1Heart Failure
11/2020
1Hypertrophy
11/2020
1Myocardial Infarction
11/2020
1Lymphoma (Lymphomas)
04/2016
1Leukemia
04/2016
1Hypersensitivity (Allergy)
02/2011

Drug/Important Bio-Agent (IBA)

4Phosphotransferases (Kinase)IBA
01/2019 - 02/2015
2Proteins (Proteins, Gene)FDA Link
11/2020 - 11/2019
2proto-oncogene proteins pimIBA
02/2015 - 02/2015
1Fatty Acids (Saturated Fatty Acids)IBA
11/2020
1Peptides (Polypeptides)IBA
11/2020
1Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2020
1sotorasibIBA
01/2020
1Cysteine (L-Cysteine)FDA Link
11/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1compound 17IBA
01/2016
1Dihydrotachysterol (AT 10)IBA
02/2015
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2015
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2012
14- (2- ((6- methoxypyridin- 3- yl)amino)- 5- ((4- (methylsulfonyl)piperazin- 1- yl)methyl)pyridin- 3- yl)- 6- methyl- 1,3,5- triazin- 2- amineIBA
09/2012
1AntigensIBA
02/2011

Therapy/Procedure

2Therapeutics
02/2015 - 09/2012